The day of the central banks



A look at the day ahead from Sujata Rao

Vaccinations are just getting off the ground so there is not a whole lot central banks can do at this point. The Bank of Japan confined itself to marginally upping 2021 GDP growth forecasts but held off extending the target band for 10-year yields as had been speculated.

Similarly, it's too soon for the European Central Bank to act after it extended asset purchases last month but after five straight months of negative inflation readings, markets will seek the ECB's views on euro strength, how much of its emergency stimulus "envelope" it might spend and whether yield -- or rather spread - control is likely.

Nor are policymakers expected to do much in Norway, South Africa and Turkey, though there is a slim chance of a hike in Turkey where the new governor has hiked rates 675 basis points since early November.

Back on markets, so much for Donald Trump's warnings of a stock market crash should Joe Biden become president -- Wall Street scaled new record highs after Biden's inauguration and futures imply further gains ahead in New York as well as across Europe.

Watch out for weekly U.S. jobless figures which are expected to stay close to the one million-mark, reinforcing the need to quickly get Biden's planned stimulus package off the mark.

In keeping with the risk-on mode, the dollar is slipping, benefiting commodity currencies such as the Aussie and Canadian dollars. Sterling is above $1.37, near 2-1/2-year highs.

Key developments that should provide more direction to markets on Thursday: -European Central Bank -Norges Bank -UK CBI business sentiment/new orders -South African Reserve Bank -Central Bank of Turkey -U.S. initial jobless claims -US Treasury to sell $15 billion in 10-year TIPS -U.S. earnings: Coca Cola, American airlines, Southwest Airlines, American Express, Carnival Corp, IBM, Intel -Europe earnings: Spain's Bankinter said 2020 net profits fell 42.4% vs previous year -Julius Baer shares marked down 1% after industry watchdog FINMA launched proceedings against a senior manager and reprimanded two others over failure to prevent money laundering.



Next up in yield curve control: ECB? Link



Reporting by Sujata Rao

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.